Literature DB >> 22472310

Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.

John Cookson1, Richard Hodgson, Hiram J Wildgust.   

Abstract

Hyperprolactinaemia is a common side effect of antipsychotics; markedly raised levels are less common. Higher levels of prolactin result from longer exposure to higher doses, especially with older antipsychotics or with risperidone, sulpiride or amisulpride. Galactorrhoea, gynaecomastia, menstrual abnormalities and sexual dysfunction including hypogonadism and fertility problems are consequences of raised prolactin, and in the longer-term bone demineralisation. Younger patients may be more susceptible to hyperprolactinaemia. Trial reports often fail to state the frequency of raised levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472310     DOI: 10.1177/0269881112442016

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  26 in total

Review 1.  Functional hypothalamic and drug-induced amenorrhea: an overview.

Authors:  A Lania; L Gianotti; I Gagliardi; M Bondanelli; W Vena; M R Ambrosio
Journal:  J Endocrinol Invest       Date:  2019-02-11       Impact factor: 4.256

Review 2.  The quality of lactation studies including antipsychotics.

Authors:  Hazel Hummels; Daphne Bertholee; Douwe van der Meer; Jan Pieter Smit; Bob Wilffert; Peter Ter Horst
Journal:  Eur J Clin Pharmacol       Date:  2016-08-24       Impact factor: 2.953

Review 3.  Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

Authors:  Gavin P Reynolds; Olga O McGowan; Caroline F Dalton
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

4.  Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons.

Authors:  Hae-Young Hawong; Joseph R Patterson; Brittany M Winner; John L Goudreau; Keith J Lookingland
Journal:  Brain Res       Date:  2015-07-02       Impact factor: 3.252

5.  The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients.

Authors:  Süheyla Doğan Bulut; Serdar Bulut; Verda Tüzer; Mehmet Ak; Emine Ak; Cebrail Kisa; Çiğdem Aydemir; Erol Göka
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

Review 6.  Antipsychotic-induced hyperprolactinemia in Tourette syndrome.

Authors:  Judith J G Rath; Marlies E J Deen; Hessel van Houten; Sebastiaan F T M de Bruijn; Joop van Gerven; Dick Mul
Journal:  Ther Adv Psychopharmacol       Date:  2017-04-21

7.  Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.

Authors:  Erik Johnsen; Rune A Kroken
Journal:  Ther Adv Chronic Dis       Date:  2012-11       Impact factor: 5.091

8.  Shift in Kiss1 cell activity requires estrogen receptor α.

Authors:  Renata Frazão; Roberta M Cravo; Jose Donato; Dhirender V Ratra; Deborah J Clegg; Joel K Elmquist; Jeffrey M Zigman; Kevin W Williams; Carol F Elias
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

Review 9.  Prolactin serum concentrations during aripiprazole treatment in youth.

Authors:  Daniel J Safer; Chadi A Calarge; Alan M Safer
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-05-06       Impact factor: 2.576

Review 10.  Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.

Authors:  Frank M C Besag; Michael J Vasey; Iffah Salim
Journal:  CNS Drugs       Date:  2021-04-20       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.